BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

950 related articles for article (PubMed ID: 18042732)

  • 1. 2-[2-(3,4-dichloro-phenyl)-2,3-dihydro-1H-isoindol-5-ylamino]-nicotinic acid (PD-307243) causes instantaneous current through human ether-a-go-go-related gene potassium channels.
    Gordon E; Lozinskaya IM; Lin Z; Semus SF; Blaney FE; Willette RN; Xu X
    Mol Pharmacol; 2008 Mar; 73(3):639-51. PubMed ID: 18042732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Electrophysiologic characterization of a novel hERG channel activator.
    Su Z; Limberis J; Souers A; Kym P; Mikhail A; Houseman K; Diaz G; Liu X; Martin RL; Cox BF; Gintant GA
    Biochem Pharmacol; 2009 Apr; 77(8):1383-90. PubMed ID: 19426677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological removal of human ether-à-go-go-related gene potassium channel inactivation by 3-nitro-N-(4-phenoxyphenyl) benzamide (ICA-105574).
    Gerlach AC; Stoehr SJ; Castle NA
    Mol Pharmacol; 2010 Jan; 77(1):58-68. PubMed ID: 19805508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiac glycosides as novel inhibitors of human ether-a-go-go-related gene channel trafficking.
    Wang L; Wible BA; Wan X; Ficker E
    J Pharmacol Exp Ther; 2007 Feb; 320(2):525-34. PubMed ID: 17095614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Time course and voltage dependence of expressed HERG current compared with native "rapid" delayed rectifier K current during the cardiac ventricular action potential.
    Hancox JC; Levi AJ; Witchel HJ
    Pflugers Arch; 1998 Nov; 436(6):843-53. PubMed ID: 9799397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutant MiRP1 subunits modulate HERG K+ channel gating: a mechanism for pro-arrhythmia in long QT syndrome type 6.
    Lu Y; Mahaut-Smith MP; Huang CL; Vandenberg JI
    J Physiol; 2003 Aug; 551(Pt 1):253-62. PubMed ID: 12923204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Probing the binding sites and mechanisms of action of two human ether-a-go-go-related gene channel activators, 1,3-bis-(2-hydroxy-5-trifluoromethyl-phenyl)-urea (NS1643) and 2-[2-(3,4-dichloro-phenyl)-2,3-dihydro-1H-isoindol-5-ylamino]-nicotinic acid (PD307243).
    Xu X; Recanatini M; Roberti M; Tseng GN
    Mol Pharmacol; 2008 Jun; 73(6):1709-21. PubMed ID: 18372399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HERG mutation predicts short QT based on channel kinetics but causes long QT by heterotetrameric trafficking deficiency.
    Paulussen AD; Raes A; Jongbloed RJ; Gilissen RA; Wilde AA; Snyders DJ; Smeets HJ; Aerssens J
    Cardiovasc Res; 2005 Aug; 67(3):467-75. PubMed ID: 15958262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The action of the novel gastrointestinal prokinetic prucalopride on the HERG K+ channel and the common T897 polymorph.
    Chapman H; Pasternack M
    Eur J Pharmacol; 2007 Jan; 554(2-3):98-105. PubMed ID: 17109852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of sophocarpine on HERG K+ channels].
    Qi ZP; Shi SS; Zhao XL; Zhao WX; Bai YL; Lü YJ; Li BX; Yang BF
    Yao Xue Xue Bao; 2008 Jan; 43(1):44-9. PubMed ID: 18357730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The membrane permeable calcium chelator BAPTA-AM directly blocks human ether a-go-go-related gene potassium channels stably expressed in HEK 293 cells.
    Tang Q; Jin MW; Xiang JZ; Dong MQ; Sun HY; Lau CP; Li GR
    Biochem Pharmacol; 2007 Dec; 74(11):1596-607. PubMed ID: 17826747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alteration of HERG current profile during the cardiac ventricular action potential, following a pore mutation.
    Hancox JC; Witchel HJ; Varghese A
    Biochem Biophys Res Commun; 1998 Dec; 253(3):719-24. PubMed ID: 9918793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of HERG channels by the local anaesthetic articaine.
    Siebrands CC; Friederich P
    Eur J Anaesthesiol; 2007 Feb; 24(2):148-53. PubMed ID: 16938156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The human ether-a-go-go-related gene (hERG) current inhibition selectively prolongs action potential of midmyocardial cells to augment transmural dispersion.
    Yasuda C; Yasuda S; Yamashita H; Okada J; Hisada T; Sugiura S
    J Physiol Pharmacol; 2015 Aug; 66(4):599-607. PubMed ID: 26348084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blockade of HERG human K+ channel and IKr of guinea pig cardiomyocytes by prochlorperazine.
    Kim MD; Eun SY; Jo SH
    Eur J Pharmacol; 2006 Aug; 544(1-3):82-90. PubMed ID: 16860311
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of human ether-a-go-go-related gene K+ channel and IKr of guinea pig cardiomyocytes by antipsychotic drug trifluoperazine.
    Choi SY; Koh YS; Jo SH
    J Pharmacol Exp Ther; 2005 May; 313(2):888-95. PubMed ID: 15722405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hydrogen peroxide modifies the kinetics of HERG channel expressed in a mammalian cell line.
    Bérubé J; Caouette D; Daleau P
    J Pharmacol Exp Ther; 2001 Apr; 297(1):96-102. PubMed ID: 11259532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mallotoxin is a novel human ether-a-go-go-related gene (hERG) potassium channel activator.
    Zeng H; Lozinskaya IM; Lin Z; Willette RN; Brooks DP; Xu X
    J Pharmacol Exp Ther; 2006 Nov; 319(2):957-62. PubMed ID: 16928897
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pentamidine-induced long QT syndrome and block of hERG trafficking.
    Kuryshev YA; Ficker E; Wang L; Hawryluk P; Dennis AT; Wible BA; Brown AM; Kang J; Chen XL; Sawamura K; Reynolds W; Rampe D
    J Pharmacol Exp Ther; 2005 Jan; 312(1):316-23. PubMed ID: 15340016
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibitory effects of coronary vasodilator papaverine on heterologously-expressed HERG currents in Xenopus oocytes.
    Kim CS; Lee N; Son SJ; Lee KS; Kim HS; Kwak YG; Chae SW; Lee SD; Jeon BH; Park JB
    Acta Pharmacol Sin; 2007 Apr; 28(4):503-10. PubMed ID: 17376289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 48.